Menstrual effects on mood symptoms in treated women with bipolar disorder

Bipolar Disorders

Volumn 13, Issue 3, 2011, Pages 310-317

  Sit, Dorothy ^a   Seltman, Howard ^b   Wisner, Katherine L ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Follicular phase; Luteal phase; Menstrual cycle; Women

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; CARBAMAZEPINE; CITALOPRAM; FLUOXETINE; LAMOTRIGINE; LITHIUM; LUTEINIZING HORMONE; PROGESTERONE; RISPERIDONE; SERTRALINE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLICULAR PHASE; HAMILTON SCALE; HUMAN; HYPOMANIA; LUTEAL PHASE; MANIA; MENSTRUAL CYCLE; MOOD CHANGE; OVULATION; PREMENSTRUAL DYSPHORIC DISORDER; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; SELF REPORT; SOCIAL INTERACTION; SOCIAL PSYCHOLOGY; STRESS; STRUCTURED INTERVIEW;

ADOLESCENT; ADULT; AFFECT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 79959215510     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2011.00921.x     Document Type: Article

References (43)

1. Goodwin FK, Jamison KR. Suicide in Manic-Depressive Disorder. New York: Oxford University Press, 1990: 227-244.
2. Leibenluft E. Women with bipolar illness: clinical and research issues. Am J Psychiatry 1996; 153: 163-173.
3. Papadimitriou GN, Calabrese JR, Dikeos DG, Christodoulou GN. Rapid cycling bipolar disorder: biology and pathogenesis. Int J Neuropsychopharmacology 2005; 8: 281-292.
4. Judd LL, Akiskal HS, Schettler PJ et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002; 59: 530-537.
5. Robb JC, Cooke RG, Devins GM, Young LT, Joffe RT. Quality of life and lifestyle disruption in euthymic bipolar disorder. J Psychiatr Res 1997; 31: 509-517.
6. Blehar MC, DePaulo JR Jr, Gershon ES, Reich T, Simpson SG, Nurnberger JI Jr. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacology Bull 1998; 34: 239-243.
7. Rasgon N, Bauer M, Glenn T, Elman S, Whybrow PC. Menstrual cycle related mood changes in women with bipolar disorder. Bipolar Disord 2003; 5: 48-52.
8. Hendrick V, Altshuler LL, Burt VK. Course of psychiatric disorders across the menstrual cycle. Harv Rev Psychiatry 1996; 4: 200-207.
9. Bäckström T, Hansson-Malmström Y, Lindhe BA, Cavalli-Björkman B, Nordenström S. Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations. Contraception 1992; 46: 253-268.
10. Rapkin A. A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder. Psychoneuroendocrinology 2003; 28: 39-53.
11. Fuhrmann U, Krattenmacher R, Slater EP, Frizemeier KH. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 1996; 54: 243-251.
12. Becker JB, Arnold AP, Berkley KJ et al. Strategies and methods for research on sex differences in brain and behavior. Endocrinology 2005; 146: 1650-1673.
13. Parry BL. Psychobiology of premenstrual dysphoric disorder. Semin Reprod Endocrinol 1997; 15: 55-68.
14. Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychol Med 2002; 32: 119-132.
15. American Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders, 4th Ed. (DSM-IV) Washington, DC: American Psychiatric Association, 1994.
16. Rasgon NL, Altshuler LL, Fairbanks L et al. Reproductive function and risk for PCOS in women treated for bipolar disorder. Bipolar Disord 2005; 7: 246-259.
17. Joffe H, Cohen LS, Suppes T et al. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder. Biol Psychiatry 2006; 59: 1078-1086.
18. Karadag F, Akdeniz F, Erten E et al. Menstrually related symptom changes in women with treatment-responsive bipolar disorder. Bipolar Disord 2004; 6: 253-259.
19. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 1998; 338: 209-216.
20. Marcus M, Loucks TL, Berga SL. Psychological correlates of functional hypothalamic amenorrhea. Fertil Steril 2001; 76: 310-316.
21. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition. Washington, DC: American Psychiatric Press, 1996.
22. Williams JBW, Terman M. Structured Interview Guide for the Hamilton Depression Rating Scale with Atypical Depression Supplement (SIGH-ADS). New York: New York State Psychiatric Institute, 2003.
23. Endicott J, Spitzer RL. A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry 1978; 35: 837-844.
24. Ware JE, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-233.
25. Behre HM, Kuhlage J, Gabner C et al. Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod 2000; 15: 2478-2482.
26. Halbreich U, Endicott J. Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand 1985; 71: 331-338.
27. Meaden PM, Daniels RE, Zajecka J. Construct validity of life chart functioning scales for use in naturalistic studies of bipolar disorder. J Psychiatr Res 2000; 34: 187-192.
28. Faraway JJ. Extending the Linear Model with R: Generalized Linear, Mixed Effects and Nonparametric Regression Models. Danvers: Chapman & Hall/CRC Texts in Statistical Science, Taylor and Francis Group, 2005.
29. Shivakumar G, Bernstein IH, Suppes T et al. Are bipolar mood symptoms affected by the phase of the menstrual cycle? J Womens Health 2008; 17: 473-478.
30. Payne JL, Roy PS, Murphy-Eberenz K et al. Reproductive cycle-associated mood symptoms in women with major depression and bipolar disorder. J Affect Disord 2007; 99: 221-229.
31. Joffe H, Kim DR, Foris JM et al. Menstrual dysfunction prior to onset of psychiatric illness is reported more commonly by women with bipolar disorder than by women with unipolar depression and healthy controls. J Clin Psychiatry 2006; 67: 297-304.
32. Bäckström T, Andersson A, Andree L et al. Pathogenesis in menstrual cycle-linked CNS disorders. Ann N Y Acad Sci 2003; 1007: 42-53.
33. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998; 392: 926-930.
34. Agís-Balboa RC, Pinna G, Zhubi A et al. Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. Proc Natl Acad Sci USA 2006; 103: 14602-14607.
35. A receptor plasticity. Psychoneuroendocrinology 2009; 34 (Suppl. 1): S91-S103.
36. Guidotti A, Costa E. Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability? Biol Psychiatry 1998; 44: 865-873.
37. Pinna G, Costa E, Guidotti A. Fluoxetine and norfluoxetine stereospecifically and selectively increase brain neurosteroid content at doses that are inactive on 5-HT reuptake. Psychopharmacology 2006; 186: 362-372.
38. Rasgon NL, Reynolds MF, Elman S et al. Longitudinal evaluation of reproductive function in women treated for bipolar disorder. J Affect Disord 2005; 89: 217-225.
39. Friedman SD, Dager SR, Parow A et al. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder. Biol Psychiatry 2004; 56: 340-348.
40. Shibuya-Tayoshi S, Tayoshi S, Sumitani S, Ueno S, Harada M, Ohmori T. Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy. Prog Neuropsychopharmacology Biol Psychiatry 2008; 32: 249-256.
41. Reimers A, Brodtkorb E, Helde G, Spigset O. Lamotrigine serum concentrations throughout the menstrual cycle-a study of 2 cases. Clin Neuropharmacol 2006; 29: 160-162.
42. Steiner M, Steinberg S, Stewart D et al. Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med 1995; 332: 1529-1534.
43. Freeman EW, Rickels K, Sammel MD, Lin H, Sondheimer SJ. Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline. Arch Gen Psychiatry 2009; 66: 537-544.